secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001193125-24-156113
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soleno shareholders elect director, ratify auditor, and approve expanded equity incentive plan
--------------------------------------------------------------------------------

- Andrew Sinclair elected as Class I director with 93.3% of votes cast (26.4M for, 1.9M withheld).
- Marcum LLP ratified as independent auditor for FY 2024 (29.2M for, 135K against).
- Amended 2014 Equity Incentive Plan approved (19.4M for, 8.9M against); share pool set at 5,825,762 shares plus annual 4% evergreen increase.
- Voter turnout of 87.7% (29,312,453 of 33,411,329 shares outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524156113/0001193125-24-156113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524156113/d834951d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-156113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer